Advisory Boards

External Advisory Committee

An EAC of eminent scholars representing basic, translational and clinical neurosciences has been created and the composition of this Board is shown below. The EAC meets twice a year, once by teleconference and the second as a face-to-face meeting at the University of Kansas. During the latter meeting, members review the structure, function and scientific accomplishments of the program sponsored by CBID. They attend presentations made by the CBID-supported scientists and Core leaders, and they make recommendations to the PI and Co-Is on the quality of progress being made by the CBID program. Members of the EAC also meet individually with the Project Investigators to assess the quality of their experiences in terms of mentoring and the operations of the Core facilities, as well as to discuss the scientific accomplishments in their respective projects and their future plans. The EAC also reviews the funding recommendations made by the IAB and make final recommendations for funding of Research Project grants.

The advice and recommendations offered by the EAC are recorded, considered and followed by the PI and Co-Is, including recommendations to change the funding of Investigator Projects, to alter the training components of the CBID, or to alter the function and organization of the Cores. The PI and Co-Is discuss such recommendations with the Investigators and their mentors in the CBID, and/or with the Directors of the various Cores and their Steering Committees, in order to develop appropriate plans to deal with the recommended changes. Key criteria and milestones are developed together with the Investigators and Directors to assess performance and accomplishment of goals suggested by the EAC. The PI and Co-Is consult frequently with the EAC and IAB during the execution of any substantive programmatic changes and update both the EAC and IAB about progress and outcomes resulting from the recommended changes. These changes are also discussed at the next scheduled EAC and IAB meeting.

Darrin Akins photo

Darrin Akins
Associate Dean for Research and Professor of Microbiology and Immunology
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center



Jeff Aubé photo

Jeff Aubé
Fred Eshelman Distinguished Professor
Eshelman School of Pharmacy, University of North Carolina, Chapel Hil



Victor DiRita photo

Victor DiRita
Rudolph Hugh Professor & Chair
Department of Microbiology & Molecular Genetics, Michigan State University



Alexander MacKerell photo

Alexander MacKerell
Grollman-Glick Professor of Pharmaceutical Sciences and Director of the Computer-Aided Drug Design Center
School of Pharmacy, University of Maryland



Tom Prisinzano photo

Thomas Prisinzano
College of Pharmacy, University of Kentucky



Internal Advisory Board

The IAB reviews the activities of the CBID twice a year and makes recommendations to the PI and Co-I for changes in the management and focus of the Program. The meetings of the IAC are at alternate six-month intervals from those of the EAC. The advice of the IAB is not meant to supplant that of the EAC, only to offer an additional period of review and assessment of meeting the milestones set at the beginning of each Project Grant or of the Cores. The advice of the IAB is discussed with the EAC and the recommendations of the two committees implemented.

Robert Hanzlik photo

Robert Hanzlik
Department of Medicinal Chemistry, University of Kansas



Susan Lunte photo

Susan Lunte
Distinguished Professor
Pharmaceutical Chemistry, University of Kansas



Joe Lutkenhaus photo

Joe Lutkenhaus
University Distinguished Professor
Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center




KU Today